Nigro, M. C.; Marchetti, A.; Fumagalli, E. R.; De Luca, I.; Bertuzzi, A. F.; Grimaudo, M. S.; Grignani, G.; D'Ambrosio, L.; Merlini, A.; Badalamenti, G.; Incorvaia, L.; Dimino, A.; Gasperoni, S.; Vincenzi, B.; Fanti, S.; Di Federico, A.; Campana, D.; Pantaleo, M. A.; Nannini, M., 18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors, «JAMA NETWORK OPEN», 2025, 8, Article number: e2456058 , pp. 1 - 11 [Scientific article]Open Access
DE BIASE, Dario; Repaci, Andrea; Nigro, MARIA CONCETTA; Maloberti, Thais; Carosi, Francesca; Pantaleo, Maria A.; Tallini, Giovanni; Nannini, Margherita, The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC), «JOURNAL OF CLINICAL & TRANSLATIONAL ENDOCRINOLOGY», 2024, 38, Article number: 100373 , pp. 1 - 3 [Scientific article]Open Access
Nannini, M.; Repaci, A.; Nigro, M. C.; Colapinto, A.; Vicennati, V.; Maloberti, T.; Gruppioni, E.; Altimari, A.; Solaroli, E.; Lodi Rizzini, E.; Monari, F.; De Leo, A.; Damiani, S.; Pagotto, U.; Pantaleo, M. A.; de Biase, D.; Tallini, G., Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer, «ESMO OPEN», 2023, 8, Article number: 102039 , pp. 102039 - 102039 [Scientific article]Open Access
Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A., Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review, «LUNG CANCER: TARGETS AND THERAPY», 2023, 14, pp. 11 - 25 [Scientific article]
Gozzellino, Livia; Nannini, Margherita; Urbini, Milena; Pizzi, Carmine; Leone, Ornella; Corti, Barbara; Baldovini, Chiara; Angeli, Francesco; Foà, Alberto; Pacini, Davide; Folesani, Gianluca; Costa, Alice; Palumbo, Teresa; Nigro, Maria Concetta; Pasquinelli, Gianandrea; Astolfi, Annalisa; Pantaleo, Maria Abbondanza, Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas, «BIOMEDICINES», 2023, 11, Article number: 3290 , pp. 1 - 14 [Scientific article]Open Access
Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco, Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis, «IMMUNOTHERAPY», 2023, 1, pp. 1 - 10 [Scientific article]
Elisa Tassinari, Nicole Conci, Giacomo Battisti, Francesco Porta, Valerio Di Scioscio, Maria Giulia Pirini, Dario de Biase, Maria Concetta Nigro, Miriam Iezza, Fausto Castagnetti, Luigi Lovato, Stefano Fanti, Maria Abbondanza Pantaleo, Margherita Nannini, Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report, «FRONTIERS IN ONCOLOGY», 2023, 13, pp. 1 - 6 [Scientific article]Open Access
Mosca M.; Nigro M.C.; Pagani R.; De Giglio A.; Di Federico A., Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond, «BIOMOLECULES», 2023, 13, Article number: 1803 , pp. 1 - 15 [Scientific article]Open Access
Mollica V.; Nuvola G.; Tassinari E.; Nigro M.C.; Marchetti A.; Rosellini M.; Rizzo A.; Errani C.; Massari F., Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw, «CURRENT ONCOLOGY», 2022, 29, pp. 1709 - 1722 [Scientific article]Open Access
Nigro M.C.; Mollica V.; Marchetti A.; Cheng M.; Rosellini M.; Montironi R.; Cheng L.; Massari F., Current androgen receptor antagonists under investigation for resistant prostate cancer, «EXPERT REVIEW OF ANTICANCER THERAPY», 2022, 22, pp. 191 - 202 [Scientific article]
Nigro M.C.; Pirini M.G.; Garelli E.; Marchi M.; Musto A.; Pantaleo M.A.; Solli P.; Ardizzoni A.; Nannini M., Thoracic myopericytoma in an older adult, rare but possible: A case report, «THORACIC CANCER», 2022, 13, pp. 2532 - 2535 [Scientific article]Open Access
Comito F.; Nigro M.C.; Sperandi F.; Melotti B.; Ardizzoni A., Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab, «EUROPEAN JOURNAL OF CANCER», 2021, 146, pp. 84 - 86 [Scientific article]
Nannini, M.; Rizzo, A.; Nigro, M. C.; Vincenzi, B.; Mazzocca, A.; Grignani, G.; Merlini, A.; D'Ambrosio, L.; Tolomeo, F.; Badalamenti, G.; Incorvaia, L.; Bonasera, A.; Fumagalli, E.; Miliziano, D.; Ligorio, F.; Brunello, A.; Chiusole, B.; Gasperoni, S.; Novelli, M.; Pantaleo, M. A., Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study, «ESMO OPEN», 2021, 6, Article number: 100222 , pp. 100222 - 100228 [Scientific article]Open Access
Nannini, Margherita; Rizzo, Alessandro; Nigro, Maria Concetta; Vincenzi, Bruno; Mazzocca, Alessandro; Grignani, Giovanni; Tolomeo, Francesco; D'Ambrosio, Lorenzo; Badalamenti, Giuseppe; Bonasera, Annalisa; Fumagalli, Elena; Miliziano, Daniela; Brunello, Antonella; Chiusole, Benedetta; Gasperoni, Silvia; Novelli, Marco; Pantaleo, Maria A., Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study, «JOURNAL OF CLINICAL ONCOLOGY», 2021, 39, Article number: e23521 , pp. 1 - 1 [Scientific article]
Rizzo A.; Ricci A.D.; Tober N.; Nigro M.C.; Mosca M.; Palloni A.; Abbati F.; Frega G.; De Lorenzo S.; Tavolari S.; Brandi G., Second-line treatment in advanced biliary tract cancer: Today and tomorrow, «ANTICANCER RESEARCH», 2020, 40, pp. 3013 - 3030 [Scientific article]
